What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Dopamine
His primary areas of investigation include Neuroscience, Parkinson's disease, Dopamine, Dyskinesia and MPTP.
The Neuroscience study combines topics in areas such as Parkinsonism and Subthalamic nucleus.
Erwan Bezard has researched Parkinson's disease in several fields, including Neurodegeneration and Neuroprotection.
His biological study spans a wide range of topics, including Degeneration and Receptor.
His studies in Dyskinesia integrate themes in fields like Levodopa and Dopamine receptor, Dopamine receptor D3.
His work deals with themes such as Neurotoxin and Dopamine Plasma Membrane Transport Proteins, which intersect with MPTP.
His most cited work include:
- Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms (545 citations)
- Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies (405 citations)
- Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease (402 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Neuroscience, Parkinson's disease, Dopamine, Dyskinesia and MPTP.
His Neuroscience study combines topics in areas such as Disease and Parkinsonism.
His Parkinson's disease research includes themes of Agonist, Neurodegeneration, Neuroprotection, Putamen and Degenerative disease.
As part of his research on Dopamine, studies on Endocrinology and Internal medicine are part of the effort.
His research in Dyskinesia intersects with topics in Levodopa, Pharmacology and Dopamine receptor D3.
His MPTP research integrates issues from Dopamine transporter, Neurotoxin, Tyrosine hydroxylase and Macaque.
He most often published in these fields:
- Neuroscience (70.38%)
- Parkinson's disease (50.56%)
- Dopamine (43.21%)
What were the highlights of his more recent work (between 2018-2021)?
- Neuroscience (70.38%)
- Parkinson's disease (50.56%)
- Dopamine (43.21%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Neuroscience, Parkinson's disease, Dopamine, Dopaminergic and Dyskinesia.
His Neuroscience research incorporates themes from Receptor and Disease, Neurodegeneration.
His work carried out in the field of Parkinson's disease brings together such families of science as Autophagy and Agonist.
Erwan Bezard works on Dopamine which deals in particular with Striatum.
His Dopaminergic research is multidisciplinary, incorporating elements of Protein aggregation, Intracellular, Dystonia, Basal ganglia and Mediator.
His Dyskinesia study incorporates themes from Cholinergic, Circadian rhythm, Physical medicine and rehabilitation and Pharmacology.
Between 2018 and 2021, his most popular works were:
- TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. (58 citations)
- TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. (58 citations)
- Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging. (27 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Dopamine
Erwan Bezard focuses on Neuroscience, Dopaminergic, Parkinson's disease, Neurodegeneration and Dopamine.
His Neuroscience study integrates concerns from other disciplines, such as Pathological, Disease, Parkinsonism and Signal transduction.
His studies deal with areas such as Serotonergic, Neurotransmitter and Mass spectrometry as well as Dopaminergic.
Many of his research projects under Parkinson's disease are closely connected to Glycine binding with Glycine binding, tying the diverse disciplines of science together.
His biological study focuses on Striatum.
His Striatum study which covers Dyskinesia that intersects with Pharmacology, Guanine nucleotide exchange factor and PI3K/AKT/mTOR pathway.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
